Intrinsic Value of S&P & Nasdaq Contact Us

Pulse Biosciences, Inc. PLSE NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
44/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$30.00
+49.1%

Stock Statistics — PLSE

Pulse Biosciences, Inc. (PLSE) has a market capitalization of $1.37B and trades at $20.12. The 52-week range is 12.56-26.3.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18.6, Earnings Per Share (EPS) of $-1.08, annual revenue of $350K.

The stock has a beta of 1.82, operates in the Healthcare sector.

Trading Data
Current Price$20.12
52-Week Range12.56-26.3
Volume250.16K
Avg Volume (30D)350.58K
Market Cap$1.37B
Beta (1Y)1.82
Company
IPO Date2016-05-18
Employees75
CEOPaul Arthur LaViolette
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS74587B1017
CUSIP74587B101
Income (Latest Year)
Revenue$350K
Gross Profit$-1.26M
EBITDA$-71.71M
Operating Income$-76.94M
Net Income$-72.78M
EPS$-1.08
EPS Diluted$-1.08
Shares Outstanding$67.4M
Balance Sheet (Latest Year)
Total Assets$96.11M
Current Assets$83.42M
Cash & ST Investments$80.74M
Total Liabilities$15.46M
Total Debt$7.53M
Net Debt$-73.21M
Total Equity$80.66M
Debt / Equity0.09
Valuation Ratios
P/E Ratio-18.6
P/S Ratio3908.4
P/B Ratio16.96
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message